Avanir Pharmaceuticals Inc:企業の戦略的SWOT分析

【英語タイトル】Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C15313)・商品コード:DATA904C15313
・発行会社(調査会社):GlobalData
・発行日:2019年3月
・ページ数:22
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Avanir Pharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Avanir Pharmaceuticals Inc (Avanir), a subsidiary of Otsuka Pharmaceutical Co Ltd. is a biopharmaceutical company that focuses on the research, development and commercialization of medical and pharmaceutical treatments for central nervous system disorders. The company’s lead products include NUEDEXTA, a medication used for the treatment of pseudobulbar affect (PBA); and ONZETRA Xsail, an intranasal medication delivery system used for the treatment of migraine. Its pipeline products are intended for the treatment of pseudobulbar affect, acute treatment of migraine, acute treatment of migraine in pediatrics, agitation in Alzheimer’s disease, residual schizophrenia, disinhibition in dementia and traumatic brain injury behavioral dysfunction, among others. Avanir is headquartered in Aliso Viejo, California, the US.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Avanir Pharmaceuticals Inc – Key Facts
Avanir Pharmaceuticals Inc – Key Employees
Avanir Pharmaceuticals Inc – Key Employee Biographies
Avanir Pharmaceuticals Inc – Major Products and Services
Avanir Pharmaceuticals Inc – History
Avanir Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Avanir Pharmaceuticals Inc – Business Description
Avanir Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Avanir Pharmaceuticals Inc – Strengths
Avanir Pharmaceuticals Inc – Weaknesses
Avanir Pharmaceuticals Inc – Opportunities
Avanir Pharmaceuticals Inc – Threats
Avanir Pharmaceuticals Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Avanir Pharmaceuticals Inc, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Avanir Pharmaceuticals Inc, Key Facts
Avanir Pharmaceuticals Inc, Key Employees
Avanir Pharmaceuticals Inc, Key Employee Biographies
Avanir Pharmaceuticals Inc, Major Products and Services
Avanir Pharmaceuticals Inc, History
Avanir Pharmaceuticals Inc, Subsidiaries
Avanir Pharmaceuticals Inc, Key Competitors
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Avanir Pharmaceuticals Inc, Recent Deals Summary

List of Figures
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★調査レポート[Avanir Pharmaceuticals Inc:企業の戦略的SWOT分析] (コード:DATA904C15313)販売に関する免責事項を必ずご確認ください。
★調査レポート[Avanir Pharmaceuticals Inc:企業の戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆